NextPharma invests €15 million in oral solid dosage manufacturing at Göttingen site

NextPharma completed a €15 million investment at its Göttingen site to increase oral solid dosage form manufacturing and packaging capacity, completed within 12 months.

“we have recently completed a €15 million investment at our Goettingen site.”nextpharma.com

• 1 source
• nextpharma.comNextPharma invests €15 million | NextPharmaOct 9, 2020

Summarized from public sources; check the original articles before acting on it.